metricas
covid
Buscar en
Clínica e Investigación en Arteriosclerosis (English Edition)
Toda la web
Inicio Clínica e Investigación en Arteriosclerosis (English Edition) Atherogenic indices: usefulness as predictors of cardiovascular disease
Journal Information

Statistics

Follow this link to access the full text of the article

Editorial
Atherogenic indices: usefulness as predictors of cardiovascular disease
Índices aterogénicos: utilidad como predictores en enfermedad cardiovascular
Juan José Tamarit García
Servicio de Medicina Interna, Unidad de Lípidos y Riesgo Vascular, Consorcio Hospital General Universitario de Valencia, Spain
Read
263
Times
was read the article
35
Total PDF
228
Total HTML
Share statistics
 array:22 [
  "pii" => "S2529912322000651"
  "issn" => "25299123"
  "doi" => "10.1016/j.artere.2022.09.002"
  "estado" => "S300"
  "fechaPublicacion" => "2022-09-01"
  "aid" => "653"
  "copyrightAnyo" => "2022"
  "documento" => "article"
  "crossmark" => 1
  "subdocumento" => "sco"
  "cita" => "Clin Investig Arterioscler. 2022;34:269-70"
  "abierto" => array:3 [
    "ES" => false
    "ES2" => false
    "LATM" => false
  ]
  "gratuito" => false
  "lecturas" => array:1 [
    "total" => 0
  ]
  "itemSiguiente" => array:18 [
    "pii" => "S2529912322000560"
    "issn" => "25299123"
    "doi" => "10.1016/j.artere.2022.08.001"
    "estado" => "S300"
    "fechaPublicacion" => "2022-09-01"
    "aid" => "624"
    "documento" => "article"
    "crossmark" => 1
    "subdocumento" => "fla"
    "cita" => "Clin Investig Arterioscler. 2022;34:271-84"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:1 [
      "total" => 0
    ]
    "en" => array:13 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Special article</span>"
      "titulo" => "LDL as a therapeutic target"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "271"
          "paginaFinal" => "284"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "LDL como objetivo terap&#233;utico"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:8 [
          "identificador" => "fig0055"
          "etiqueta" => "Figure 11"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr11.jpeg"
              "Alto" => 1117
              "Ancho" => 2500
              "Tamanyo" => 319815
            ]
          ]
          "detalles" => array:1 [
            0 => array:3 [
              "identificador" => "at0150"
              "detalle" => "Figure 1"
              "rol" => "short"
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0150" class="elsevierStyleSimplePara elsevierViewall">Intensity of lipid-lowering statin therapy&#46;</p> <p id="spar0155" class="elsevierStyleSimplePara elsevierViewall">Modified from Stone et al&#46;<a class="elsevierStyleCrossRef" href="#bib0285"><span class="elsevierStyleSup">60</span></a>&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "&#193;ngel D&#237;az Rodr&#237;guez, Teresa Mantilla Morat&#243;"
          "autores" => array:2 [
            0 => array:2 [
              "nombre" => "&#193;ngel"
              "apellidos" => "D&#237;az Rodr&#237;guez"
            ]
            1 => array:2 [
              "nombre" => "Teresa"
              "apellidos" => "Mantilla Morat&#243;"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S0214916821001625"
        "doi" => "10.1016/j.arteri.2019.10.008"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => false
          "ES2" => false
          "LATM" => false
        ]
        "gratuito" => false
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0214916821001625?idApp=UINPBA00004N"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2529912322000560?idApp=UINPBA00004N"
    "url" => "/25299123/0000003400000005/v1_202209250551/S2529912322000560/v1_202209250551/en/main.assets"
  ]
  "itemAnterior" => array:17 [
    "pii" => "S2529912322000602"
    "issn" => "25299123"
    "doi" => "10.1016/j.artere.2022.09.001"
    "estado" => "S300"
    "fechaPublicacion" => "2022-09-01"
    "aid" => "640"
    "documento" => "article"
    "crossmark" => 1
    "subdocumento" => "fla"
    "cita" => "Clin Investig Arterioscler. 2022;34:261-8"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:1 [
      "total" => 0
    ]
    "en" => array:13 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>"
      "titulo" => "Athrogenic indexes&#58; Useful markers for predicting metabolic syndrome in axial spondyloarthritis"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "261"
          "paginaFinal" => "268"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "&#205;ndices aterog&#233;nicos&#58; marcadores &#250;tiles para predecir el s&#237;ndrome metab&#243;lico en la espondiloartritis axial"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Figure 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 1455
              "Ancho" => 2175
              "Tamanyo" => 146130
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">ROC curve study of atherogenic indexes capacity to predict the metabolic syndrome&#46; TC&#58; total cholesterol&#44; TG&#58; triglycerides&#44; HDL<span class="elsevierStyleInf">c</span>&#58; high density lipoprotein cholesterol&#44; LDL<span class="elsevierStyleInf">c</span>&#58; low density lipoprotein cholesterol&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Maroua Slouma, Khaoula Ben Ali, Lobna Kharrat, Chadia Zouaoui, Haroun Ouertani, Imen Gharsallah"
          "autores" => array:6 [
            0 => array:2 [
              "nombre" => "Maroua"
              "apellidos" => "Slouma"
            ]
            1 => array:2 [
              "nombre" => "Khaoula"
              "apellidos" => "Ben Ali"
            ]
            2 => array:2 [
              "nombre" => "Lobna"
              "apellidos" => "Kharrat"
            ]
            3 => array:2 [
              "nombre" => "Chadia"
              "apellidos" => "Zouaoui"
            ]
            4 => array:2 [
              "nombre" => "Haroun"
              "apellidos" => "Ouertani"
            ]
            5 => array:2 [
              "nombre" => "Imen"
              "apellidos" => "Gharsallah"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2529912322000602?idApp=UINPBA00004N"
    "url" => "/25299123/0000003400000005/v1_202209250551/S2529912322000602/v1_202209250551/en/main.assets"
  ]
  "en" => array:11 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>"
    "titulo" => "Atherogenic indices&#58; usefulness as predictors of cardiovascular disease"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "269"
        "paginaFinal" => "270"
      ]
    ]
    "autores" => array:1 [
      0 => array:3 [
        "autoresLista" => "Juan Jos&#233; Tamarit Garc&#237;a"
        "autores" => array:1 [
          0 => array:3 [
            "nombre" => "Juan Jos&#233;"
            "apellidos" => "Tamarit Garc&#237;a"
            "email" => array:1 [
              0 => "juanjotamarit@gmail.com"
            ]
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:2 [
            "entidad" => "Servicio de Medicina Interna&#44; Unidad de L&#237;pidos y Riesgo Vascular&#44; Consorcio Hospital General Universitario de Valencia&#44; Spain"
            "identificador" => "aff0005"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "&#205;ndices aterog&#233;nicos&#58; utilidad como predictores en enfermedad cardiovascular"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Cardiovascular diseases &#40;CVD&#41; continue to be&#44; even in the years of the COVID-19 pandemic&#44; the leading cause of death&#44; according to data from the World Health Organisation &#40;WHO&#41;<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> in 2021&#44; with figures of around 18 million lives lost each year&#46; In Spain&#44; they are also the leading cause of death&#44; with 119&#44;853 people dying in 2020&#44; accounting for 24&#46;3&#37; of total deaths&#46;<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">Under this CVD heading we find a series of clinical manifestations &#40;ischaemic heart disease&#44; cerebrovascular disease or peripheral arterial disease&#41; whose underlying cause is arteriosclerosis&#44; defined as a chronic inflammatory process that affects the arteries of different vascular beds and is characterised by the presence of atheroma plaque &#40;lipids&#44; fibrous tissue and inflammatory cells&#41;&#44; in the intima and media layers that eventually produce a progressive loss of elasticity&#44; which can be complicated by the appearance of fissures&#44; erosion or rupture in the plaque and the formation of a thrombus&#44; which will condition the appearance distal to the lesion&#44; of ischaemia or tissue necrosis&#46;</p><p id="par0015" class="elsevierStylePara elsevierViewall">When clinicians are faced with a patient with various cardiovascular risk factors &#40;CVRF&#41;&#44; one of our first tasks is to estimate cardiovascular risk&#44; which is nothing more than calculating the probability of a given vascular event occurring in a predefined period of time&#44; according to their CVRF and the population group to which they belong&#46; In other words&#44; we try to know what the future will hold for that patient if we do not change his or her evolution&#46; After determining this level of risk&#44; we must make decisions that&#44; guided by the therapeutic objectives we set&#44; will often lead to the initiation or modification of treatment&#46;</p><p id="par0020" class="elsevierStylePara elsevierViewall">This desire to calculate cardiovascular risk in advance has generated many tables for estimating it&#44; the most widely used being those of the National Cholesterol Education Program-Adult Treatment Panel III &#40;NCEP-ATP III&#41; based on the Framingham equation modified by Wilson&#44; and the SCORE<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> &#40;Systematic COronary Risk Evaluation&#41;&#44; and its subsequent update SCORE 2 and SCORE OP&#46;<a class="elsevierStyleCrossRefs" href="#bib0020"><span class="elsevierStyleSup">4&#44;5</span></a> These tables&#44; despite having been a great advance in the calculation of CVR&#44; continue to have many limitations and we therefore continue to seek other indicators and&#47;or indices that act as early evolutionary predictors&#46;</p><p id="par0025" class="elsevierStylePara elsevierViewall">At this point&#44; it is important to remember that&#44; although atherosclerosis has a multifactorial aetiology&#44; lipid abnormalities are the main attributable risk factor for the development of CVD<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a> and account for about 50&#37; of the risk&#46; But we cannot assess cardiovascular risk in an optimal way<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a> merely with the determination of the &#34;classical&#34; serum lipid profile&#44; meaning total cholesterol &#40;TC&#41;&#44; triglycerides &#40;TG&#41;&#44; high-density lipoprotein cholesterol &#40;HDL-C&#41;&#44; low-density lipoprotein cholesterol &#40;LDL-C&#41; and non-HDL cholesterol&#46; And it is precisely to try to provide greater predictive value that several lipoprotein indices or ratios have been defined&#44; in an attempt to provide information on other clinical and&#47;or metabolic aspects&#44; such as the greater atherogenicity of some lipoproteins&#44; their inflammatory&#44; antioxidant&#44; antiaggregant&#44; vasodilator activity&#44; or their relationship with the metabolic syndrome&#46;</p><p id="par0030" class="elsevierStylePara elsevierViewall">The article by M&#46; Slouma<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">8</span></a> published in this issue of the journal <span class="elsevierStyleItalic">Cl&#237;nica e Investigaci&#243;n en Arteriosclerosis</span> attempts to shed light on the usefulness of atherogenic indices as predictors of metabolic syndrome &#40;MS&#41; in patients with axial spondyloarthritis and whether these are modified after treatment with tumour necrosis factor inhibitor drugs&#46; Their results show a higher frequency of &#40;MS&#41; in the population with axial spondyloarthritis than in the general population&#44; which is consistent with that obtained in other chronic inflammatory diseases such as psoriasis&#44; rheumatoid arthritis or systemic lupus erythematosus&#46; The fact that atherogenic indices were significantly higher in patients with MS and that some of them were associated with high disease activity&#44; as shown in their conclusions&#44; is consistent with the already known relationship between lipid alterations&#44; plaque progression&#44; inflammatory processes and atherosclerosis&#46; Undoubtedly&#44; further work should continue to explore the usefulness of these markers in the identification of subgroups of patients at high cardiovascular risk&#46;</p></span>"
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:8 [
            0 => array:3 [
              "identificador" => "bib0005"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "WHO Mortality Database"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "Organizaci&#243;n Mundial de la Salud &#91;Internet&#93;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "WWW" => array:2 [
                        "link" => "https&#58;&#47;&#47;www&#46;who&#46;int&#47;es&#47;health-topics&#47;cardiovascular-diseases&#35;tab&#61;tab&#95;1"
                        "fecha" => "2022"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0010"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "INEbase"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "Instituto Nacional de Estad&#237;stica &#91;Internet&#93;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "WWW" => array:2 [
                        "link" => "https&#58;&#47;&#47;www&#46;ine&#46;es&#47;dyngs&#47;INEbase&#47;es&#47;operacion&#46;htm&#63;c&#61;Estadistica&#95;C&#38;cid&#61;1254736176780&#38;menu&#61;ultiDatos&#38;idp&#61;1254735573175"
                        "fecha" => "2022"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0015"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Estimation of ten-year risk of fatal cardiovascular disease in Europe&#58; the SCORE project"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "R&#46;M&#46; Conroy"
                            1 => "K&#46; Py&#246;r&#228;l&#228;"
                            2 => "A&#46;P&#46; Fitzgerald"
                            3 => "S&#46; Sans"
                            4 => "A&#46; Menotti"
                            5 => "G&#46; De Backer"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/s0195-668x(03)00114-3"
                      "Revista" => array:6 [
                        "tituloSerie" => "Eur Heart J"
                        "fecha" => "2003"
                        "volumen" => "24"
                        "paginaInicial" => "987"
                        "paginaFinal" => "1003"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12788299"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0020"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "SCORE2 risk prediction algorithms&#58; new models to estimate 10-year risk of cardiovascular disease in Europe"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "SCORE2 working group and ESC Cardiovascular risk collaboration"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1093/eurheartj/ehab309"
                      "Revista" => array:6 [
                        "tituloSerie" => "Eur Heart J"
                        "fecha" => "2021"
                        "volumen" => "42"
                        "paginaInicial" => "2439"
                        "paginaFinal" => "2454"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34120177"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0025"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "SCORE2-OP risk prediction algorithms&#58; estimating Incident cardiovascular event risk in older persons in four geographical risk regions"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "SCORE2-OP working group and ESC Cardiovascular risk collaboration"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1093/eurheartj/ehab312"
                      "Revista" => array:7 [
                        "tituloSerie" => "Eur Heart J"
                        "fecha" => "2021"
                        "volumen" => "42"
                        "paginaInicial" => "2455"
                        "paginaFinal" => "2467"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34120185"
                            "web" => "Medline"
                          ]
                        ]
                        "itemHostRev" => array:3 [
                          "pii" => "S0211139X20301025"
                          "estado" => "S300"
                          "issn" => "0211139X"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0030"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries &#40;the INTERHEART study&#41;&#58; case-control study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "S&#46; Yusuf"
                            1 => "S&#46; Hawken"
                            2 => "S&#46; &#214;unpuu"
                            3 => "T&#46; Dans"
                            4 => "A&#46; Avezum"
                            5 => "F&#46; Lanas"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S0140-6736(04)17018-9"
                      "Revista" => array:7 [
                        "tituloSerie" => "Lancet"
                        "fecha" => "2004"
                        "volumen" => "364"
                        "paginaInicial" => "937"
                        "paginaFinal" => "952"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15364185"
                            "web" => "Medline"
                          ]
                        ]
                        "itemHostRev" => array:3 [
                          "pii" => "S1885585720303200"
                          "estado" => "S300"
                          "issn" => "18855857"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0035"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Coronary calcification&#44; coronary disease risk factors&#44; C-reactive protein&#44; and atherosclerotic cardiovascular disease events&#58; the St&#46; Francis Heart Study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "Y&#46; Arad"
                            1 => "K&#46;J&#46; Goodman"
                            2 => "M Roth"
                            3 => "D Newstein"
                            4 => "AD Guerci"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jacc.2005.02.088"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Am Coll Cardiol"
                        "fecha" => "2005"
                        "volumen" => "46"
                        "paginaInicial" => "158"
                        "paginaFinal" => "165"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15992651"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0040"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Athrogenic indexes&#58; Useful markers for predicting metabolic syndrome in axial spondyloarthritis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "S&#46; Maroua"
                            1 => "BA Khaoula"
                            2 => "K&#46; Lobna"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.arteri.2022.03.005"
                      "Revista" => array:2 [
                        "tituloSerie" => "Clin Investig Arterioscler"
                        "fecha" => "2022"
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/25299123/0000003400000005/v1_202209250551/S2529912322000651/v1_202209250551/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "63723"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Editorial"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/25299123/0000003400000005/v1_202209250551/S2529912322000651/v1_202209250551/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2529912322000651?idApp=UINPBA00004N"
]
Article information
ISSN: 25299123
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 5 2 7
2024 October 15 3 18
2024 September 31 2 33
2024 August 32 2 34
2024 July 11 2 13
2024 June 16 2 18
2024 May 20 5 25
2024 April 16 5 21
2024 March 12 1 13
2024 February 14 1 15
2024 January 16 2 18
2023 December 12 3 15
2023 November 7 0 7
2023 October 13 5 18
2023 September 8 0 8
Show all

Follow this link to access the full text of the article

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos